Hematologic Malignancy: Clinical Trials

2 trials for Hematologic Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2
Phase 21Active not recruiting 1

Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
CliniMACS® TCRαβ/CD19 Combined Depletion System - Myelodysplasia, Hematologic Malignancy
Phase 1 / Phase 2Active not recruitingNationwide Children's Hospital202018-03-022026-04-03
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
BPX-501 T cells, rimiducid - Hematologic Malignancy
Phase 1Active not recruitingBellicum Pharmaceuticals152018-02-012022-07-12

Narrower conditions

Hematologic Neoplasms (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm, Residual (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)

Interventions

AP 1903 reagent (1)

Sponsors

Bellicum Pharmaceuticals (1)  ·  Nationwide Children's Hospital (1)

Countries

Italy (1)  ·  United States (1)